---
title: HAS Healthcare Advanced Synthesis SA vs Micromacinazione
slug_a: hashealthcare
slug_b: micromacinazione
site: cdmo
review_signal_gate: closed
canonical_path: /compare/hashealthcare/micromacinazione
---

# HAS Healthcare Advanced Synthesis SA vs Micromacinazione

Side-by-side profile data from each company listing on this directory.

## HAS Healthcare Advanced Synthesis SA

- Profile: [/companies/hashealthcare](/companies/hashealthcare)

HAS Healthcare Advanced Synthesis SA — HAS Healthcare Advanced Synthesis is a Swiss CDMO producing cGMP APIs, HPAPIs and anticancer compounds from clinical to commercial use. Recent Swissmedic milestones include approval of its expanded Reduced Folates unit and inspection of its new ADC suite.

Services: 5. Modalities: 2. Indications: 1. Locations: 1. Certifications: 0. The strongest documented coverage currently appears in services (5).

### Services

- Small Molecule Development & Manufacturing
- API Synthesis & Manufacturing
- HPAPI Manufacturing (High-Potency)
- ADC (Antibody-Drug Conjugate) Manufacturing
- Quality Control Testing

### Modalities

- Small Molecule
- Antibody-Drug Conjugate (ADC)

### Development capabilities

- Data not yet provided.

### Manufacturing capabilities

- Drug Substance (DS)
- HPAPI

## Micromacinazione

- Profile: [/companies/micromacinazione](/companies/micromacinazione)

Micromacinazione — Swiss-based CDMO specializing in particle engineering and micronization with over 50 years of experience. Offers micronization, milling, spray drying, solid-state characterization, and complementary processing services (classification, blending, cryogenic, co-micronization, conditioning) for APIs, HPAPIs, controlled substances, and excipients from early development to commercial GMP scale.

Services: 6. Modalities: 1. Indications: 0. Locations: 2. Certifications: 1. The strongest documented coverage currently appears in services (6).

### Services

- Small Molecule Development & Manufacturing
- API Synthesis & Manufacturing
- HPAPI Manufacturing (High-Potency)
- Solid-State Chemistry & Polymorph Screening
- Process Development
- CMC Analytical Development

### Modalities

- Small Molecule

### Development capabilities

- Analytical method development
- Formulation development
- Solid-state characterization

### Manufacturing capabilities

- Drug Substance (DS)
- Max chemical: Commercial (>100 kg / tonne)
- HPAPI
- DEA licensed
- Cryogenic (−80 °C)